TSO3 to Hold Annual and Special Meeting of Shareholders on April 25, 2012

Ticker:  TSX - TOS
Shares Outstanding: 58 785 682

QUEBEC CITY, April 16, 2012 /CNW Telbec/ - TSO₃ Inc. (TSX: TOS) ("TSO₃" or the "Corporation") an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce it will hold its Annual and Special Meeting of Shareholders on Wednesday April 25, 2012.

EVENT:	TSO3 2011 ANNUAL MEETING OF SHAREHOLDERS
DATE:	WEDNESDAY APRIL 25, 2012
TIME:	10H30 EST
LOCATION:	PALAIS MONTCALM - Salle d'Youville 995 Place d'Youville, Québec  (QC),  G1R 3P1
REFERENCE:  LENGTH:	CNW GROUP APPROXIMATELY 1 HOUR 30 MINUTES

To listen to the live webcast of the event, please click on the link below. The webcast will be archived for a 90-day period.
Webcast: http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=3815680

About TSO₃
TSO₃, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential.  TSO₃ designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals.

For more information about TSO₃, visit the Company's Web site at www.tso3.com

The statements in this release and oral statements made by representatives of TSO₃ relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO₃) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO₃ to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

 

Source: TSO₃ Inc.
Information:
Caroline Côté
Director - Investor and Business Relations
[phone], Ext. 237
Email: [email protected]